Vaxxas – Needle-Free Vaccines
Last Updated: 10 May 2021
Vaxxas
Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.
The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.
Angus Foster, Chief Development and Operations Manager, Vaxxas
Company Profile
Company: Vaxxas Pty Ltd
Sector: Biotechnology
Location: Brisbane
Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.
